Konstantinos Bistas: Reduced Circulating Tregs in Pediatric Chronic Neutropenia
Konstantinos Bistas, Clinical Trial Sub-Investigator at Pediatric Oncology and Hematology Unit, National and Kapodistrian University of Athens, shared a post on LinkedIn about a recent article by Konstantina Toutoudaki et al., published in European Journal Of Haematology, adding:
“This study provides valuable insight into the pathogenesis of pediatric chronic neutropenia by demonstrating reduced circulating Tregs in both Autoimmune and Chronic Idiopathic Neutropenia.
Its assessment of the relationship between Treg levels and clinical features, particularly infection severity, adds important clinical relevance to the findings.
Definitely worth a read!”
Title: Reduced Circulating Regulatory T Cells in Autoimmune and Chronic Idiopathic Neutropenia of Childhood: An Observational Study of Clinical and Laboratory Associations
Authors: Konstantina Toutoudaki, Elena E. Solomou, Marianna Tzanoudaki, Stavros Glentis, Panagiota Perari, Panagiota Davoulou, Eftichia Theodoropoulou, Polyxeni Delaporta, Eleni Stamou, Irene Mavroudi, Charalambos Pontikoglou, Helen Papadaki, Antonis Kattamis
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 4, 2026, 03:51Riana Gjeta: Sharing Research on Blood Donor Safety in the Balkans
-
Nov 4, 2026, 03:48Umberto Pensato: World Stroke Congress – Science, Collaboration, and Recognition
-
Nov 4, 2026, 03:41Alejandro González Veliz: Understanding and Managing Stent Underexpansion
-
Nov 4, 2026, 03:26Violeta Jardin: The Evolution of Viscoelastic Testing
-
Nov 4, 2026, 03:12Daniele Sannipoli: Beyond Thrombosis Prevention in Polycythaemia Vera
-
Nov 4, 2026, 02:26Iris Paola Garcia Herrera: Antiphospholipid Antibodies in Children Beyond Thrombosis
-
Nov 4, 2026, 00:31Maria Cherska: Beyond LDL – Remnant Cholesterol and Stroke Prognosis
-
Nov 3, 2026, 22:00Ravi C Dara: What’s New in ASFA’s 10th Edition – Practical Updates for the Apheresis Clinician
-
Nov 3, 2026, 21:46Cedric Hermans: Treatment Differentiators for Shared Decision-Making in Haemophilia in 2026